Harju N, Kauppinen A, Loukovaara S
Int J Mol Sci. 2025; 26(3).
PMID: 39940795
PMC: 11817287.
DOI: 10.3390/ijms26031025.
Chen Y, Jiang M, Li L, Yang S, Liu Z, Lin S
Cell Death Dis. 2025; 16(1):49.
PMID: 39870644
PMC: 11772762.
DOI: 10.1038/s41419-025-07367-9.
Nicolini G, Casini G, Posarelli C, Amato R, Lulli M, Balzan S
Int J Mol Sci. 2024; 25(13).
PMID: 39000471
PMC: 11242054.
DOI: 10.3390/ijms25137364.
Yanik O, Ellialtioglu P, Demirel S, Batioglu F, Ozmert E
Diagnostics (Basel). 2023; 13(4).
PMID: 36832285
PMC: 9955723.
DOI: 10.3390/diagnostics13040797.
Crispin M, Gerhart J, Heffer A, Martin M, Abdalla F, Bravo-Nuevo A
Invest Ophthalmol Vis Sci. 2023; 64(2):1.
PMID: 36723927
PMC: 9904330.
DOI: 10.1167/iovs.64.2.1.
Untangling the Extracellular Matrix of Idiopathic Epiretinal Membrane: A Path Winding among Structure, Interactomics and Translational Medicine.
Bianchi L, Altera A, Barone V, Bonente D, Bacci T, De Benedetto E
Cells. 2022; 11(16).
PMID: 36010606
PMC: 9406781.
DOI: 10.3390/cells11162531.
The extracellular matrix complexity of idiopathic epiretinal membranes and the bilaminar arrangement of the associated internal limiting membrane in the posterior retina.
Altera A, Tosi G, Regoli M, De Benedetto E, Bertelli E
Graefes Arch Clin Exp Ophthalmol. 2021; 259(9):2559-2571.
PMID: 33760980
PMC: 8380574.
DOI: 10.1007/s00417-021-05156-6.
Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.
Heffer A, Wang V, Libby R, Feldon S, Woeller C, Kuriyan A
PLoS One. 2020; 15(12):e0243626.
PMID: 33347461
PMC: 7751870.
DOI: 10.1371/journal.pone.0243626.
[Proliferative vitreoretinopathy process-To heal or not to heal].
Grisanti S, Priglinger S, Hattenbach L
Ophthalmologe. 2020; 118(1):10-17.
PMID: 33326054
DOI: 10.1007/s00347-020-01294-0.
A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells.
Heffer A, Wang V, Sridhar J, Feldon S, Libby R, Woeller C
Transl Vis Sci Technol. 2020; 9(7):9.
PMID: 32832216
PMC: 7414640.
DOI: 10.1167/tvst.9.7.9.
Mesenchymal marker expression is elevated in Müller cells exposed to high glucose and in animal models of diabetic retinopathy.
Zhou T, Che D, Lan Y, Fang Z, Xie J, Gong H
Oncotarget. 2016; 8(3):4582-4594.
PMID: 27999189
PMC: 5354856.
DOI: 10.18632/oncotarget.13945.
Epo inhibits the fibrosis and migration of Müller glial cells induced by TGF-β and high glucose.
Luo W, Hu L, Li W, Xu G, Xu L, Zhang C
Graefes Arch Clin Exp Ophthalmol. 2016; 254(5):881-90.
PMID: 26907931
DOI: 10.1007/s00417-016-3290-5.
Current Trends about Inner Limiting Membrane Peeling in Surgery for Epiretinal Membranes.
Semeraro F, Morescalchi F, Duse S, Gambicorti E, Russo A, Costagliola C
J Ophthalmol. 2015; 2015:671905.
PMID: 26425352
PMC: 4573876.
DOI: 10.1155/2015/671905.
Characterization of ex vivo cultured neuronal- and glial- like cells from human idiopathic epiretinal membranes.
Andjelic S, Lumi X, Yan X, Graw J, Moe M, Facsko A
BMC Ophthalmol. 2014; 14:165.
PMID: 25540050
PMC: 4324881.
DOI: 10.1186/1471-2415-14-165.
Evaluation of proliferating cell abundance and phenotypes in proliferative diabetic retinopathy.
Feist Jr R, King J, Feist Sr R, Mason 3rd J, Morris R, Guidry C
Graefes Arch Clin Exp Ophthalmol. 2014; 253(2):229-36.
PMID: 25294353
DOI: 10.1007/s00417-014-2787-z.
Cell-mediated contraction of vitreous explants from chicken embryo: possibility of screening for therapeutic agents against proliferative vitreoretinal diseases.
Oki K, Miyata Y, Shimada A, Nagase T, Katsura Y, Kosano H
Mol Vis. 2013; 19:2374-84.
PMID: 24319331
PMC: 3850974.
Myofibroblast and extracellular matrix origins in proliferative vitreoretinopathy.
Feist Jr R, King J, Morris R, Witherspoon C, Guidry C
Graefes Arch Clin Exp Ophthalmol. 2013; 252(2):347-57.
PMID: 24276562
DOI: 10.1007/s00417-013-2531-0.
The natural history of lamellar macular holes: a spectral domain optical coherence tomography study.
Bottoni F, Peroglio Deiro A, Giani A, Orini C, Cigada M, Staurenghi G
Graefes Arch Clin Exp Ophthalmol. 2012; 251(2):467-75.
PMID: 22569859
DOI: 10.1007/s00417-012-2044-2.
Vitreous IGFBP-3 effects on Müller cell proliferation and tractional force generation.
King J, Guidry C
Invest Ophthalmol Vis Sci. 2011; 53(1):93-9.
PMID: 22110068
PMC: 3292387.
DOI: 10.1167/iovs.11-8683.
The influence of alloxan-induced diabetes on Müller cell contraction-promoting activities in vitreous.
King J, Mason 3rd J, Cartner S, Guidry C
Invest Ophthalmol Vis Sci. 2011; 52(10):7485-91.
PMID: 21862656
PMC: 3183978.
DOI: 10.1167/iovs.11-7781.